Detalles de la búsqueda
1.
A designed cyclic peptide based on Trastuzumab used to construct peptide-drug conjugates for its HER2-targeting ability.
Bioorg Chem
; 117: 105453, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34736138
2.
Exploration of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Bispecific Inhibitors Based on the Moiety of Fedratinib for Treatment of Both Hematologic Malignancies and Solid Cancers.
J Med Chem
; 66(8): 5753-5773, 2023 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37057760
3.
Emerging targeted protein degradation tools for innovative drug discovery: From classical PROTACs to the novel and beyond.
Eur J Med Chem
; 231: 114142, 2022 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35092900
4.
Structure-based discovery of receptor tyrosine kinase AXL degraders with excellent anti-tumor activity by selectively degrading AXL and inducing methuosis.
Eur J Med Chem
; 234: 114253, 2022 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35279611
Resultados
1 -
4
de 4
1
Próxima >
>>